Patient stratification in clinical glaucoma trials using the individual tear proteome
10.1038/s41598-018-30369-x
Saved in:
Main Authors: | Nättinen, J, Jylhä, A, Aapola, U, Parkkari, M, Mikhailova, A, Beuerman, R.W, Uusitalo, H |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Article |
Published: |
Nature Publishing Group
2020
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/178394 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Ocular surface status in glaucoma and ocular hypertension patients with existing corneal disorders switched from latanoprost 0.005% to tafluprost 0.0015%: comparison of two prostaglandin analogues with different concentrations of benzalkonium chloride
by: Wong, T.T, et al.
Published: (2020) -
Usage of glaucoma-specific patient-reported outcome measures (PROMs) in the Singapore context: A qualitative scoping exercise
by: Hee, O.K, et al.
Published: (2020) -
Intraocular pressure-lovering effect and safety of travoprost 0.004% and latanoprost 0.005% for the treatment of chronic angle closure glaucoma
by: Chew, P.T.K., et al.
Published: (2016) -
Anti-hypertensive medications and injurious falls in an older population of low socioeconomic status: A nested case-control study
by: Banu, Z, et al.
Published: (2020) -
A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension
by: Topouzis, F., et al.
Published: (2016)